Capital Flow Monitor · Sponsors · CIK 1816829
HighVista Biotechnology Opportunities Fund LP
C/O HIGHVISTA STRATEGIES LLC, BOSTON, MA, 02116 · (617) 406-6500
Pooled Investment Fund / Hedge Fund · Limited Partnership· inc. DELAWARE true
Fit score
—
Offering
—
Sold
$453.2M
% sold
—
Investors
55
Min investment
$500K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-06 | D/A ·current | 506(b) | — | $453.2M | — | 55 | EDGAR ↗ |
| 2025-07-11 | D/A | 506(b) | — | $434.9M | — | 50 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- N/A HighVista GP VII Limited Partnership — Executive Officer, Boston, MA
-
N/A HighVista Strategies LLC — Executive Officer, Boston, MA
3 other raises
- HighVista HFS Partners (Offshore) SPC - Portfolio A $132.9M of —
- HighVista Biotechnology Specialist Fund Ltd. $248.2M of —
- HighVista Strategic CRE Fund LP $29.6M of $29.6M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.